And it also possibly provides a promising prospect in developing ferroptosis-induction therapeutic strategy, especially for delaying or reversing the resistance of ccRCC to the anti-angiogenesis or mTOR inhibition treatment. The gene discussed is MTOR; the disease is nonpapillary renal cell carcinoma.